Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

Phase 4
3(100.0%)
3Total
Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07277257Phase 4Recruiting

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

Role: lead

NCT07140653Phase 4Recruiting

Arcuate Incisions With Light Adjustable Lens for Astigmatism Correction in Lens Surgery

Role: lead

NCT07260695Phase 4Recruiting

Odyssey Evaluation in Post LASIK Patients

Role: lead

NCT05418153Completed

Synergy Lens Outcomes Evaluation

Role: lead

NCT05604781Completed

Symfony/Synergy IOL Combination Outcomes

Role: lead

All 5 trials loaded